Order Article Reprints

Ghiglioni DG, Martino PA, Bruschi G, Vitali D, Osnaghi S, Corti MG, Beretta G. Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach. Pharmaceutics. 2020; 12(4):378. https://doi.org/10.3390/pharmaceutics12040378

Ghiglioni, Daniele Giovanni, Piera Anna Martino, Gaia Bruschi, Davide Vitali, Silvia Osnaghi, Maria Grazia Corti, and Giangiacomo Beretta. 2020. "Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach" Pharmaceutics 12, no. 4: 378. https://doi.org/10.3390/pharmaceutics12040378

Ghiglioni, D. G., Martino, P. A., Bruschi, G., Vitali, D., Osnaghi, S., Corti, M. G., & Beretta, G. (2020). Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach. Pharmaceutics, 12(4), 378. https://doi.org/10.3390/pharmaceutics12040378